Business Of Biotech

Pragmatic Computational Biology with Andrew Satz


Listen Later

We love to hear from our listeners. Send us a message.

This week's guest on the Business of Biotech, EVQLV's Andrew Satz, says AI and ML in biopharma are like sex in high school. "Many of the people who say they're doing it really aren't, and the one who really are aren't talking about it," he says. So, when it comes to the computational biology buzz, what’s real? What’s hype? What’s yielding benefit and what’s merely vaporware? In our talks with the leaders of new and emerging biotechs over the past 12 to 18 months, we've seen a steep increase in the application of – or at the very least, interest in – machine learning, AI, and computational biology tools for drug discovery, development, and beyond. Even those who are using some "ultra-light" application of new computational technology are eager to talk about it, as it’s clearly become as en-vogue as tacking “bio” onto your moniker was a few years back – even among companies who aren’t actually developing biologics. On this episode, Satz offers his take on the reality of adoption and shares advice on the fundamentals of AI and ML in biotech.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: [email protected]

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/


...more
View all episodesView all episodes
Download on the App Store

Business Of BiotechBy Ben Comer

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

84 ratings


More shows like Business Of Biotech

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,635 Listeners

WSJ What’s News by The Wall Street Journal

WSJ What’s News

4,333 Listeners

Masters in Business by Bloomberg

Masters in Business

2,153 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,060 Listeners

Acquired by Ben Gilbert and David Rosenthal

Acquired

4,228 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,448 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,022 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

61 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

Pharma and BioTech Daily by Pharma and BioTech News

Pharma and BioTech Daily

12 Listeners

Ground Truths by Eric Topol

Ground Truths

50 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

11 Listeners